Your browser doesn't support javascript.
loading
Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults.
Tippett, Ashley; Ess, Gabby; Hussaini, Laila; Reese, Olivia; Salazar, Luis; Kelly, Mary; Taylor, Meg; Ciric, Caroline; Keane, Amy; Cheng, Andrew; Gibson, Theda; Li, Wensheng; Hsiao, Hui-Mien; Bristow, Laurel; Hellmeister, Kieffer; Al-Husein, Zayna; Hubler, Robin; Begier, Elizabeth; Liu, Qing; Gessner, Bradford; Swerdlow, David L; Kamidani, Satoshi; Kao, Carol; Yildirim, Inci; Rouphael, Nadine; Rostad, Christina A; Anderson, Evan J.
Afiliação
  • Tippett A; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Ess G; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Hussaini L; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Reese O; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Salazar L; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Kelly M; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Taylor M; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Ciric C; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Keane A; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Cheng A; Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Gibson T; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Li W; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Hsiao HM; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Bristow L; Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Hellmeister K; Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Al-Husein Z; Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Hubler R; Pfizer, Inc,New York, New York, USA.
  • Begier E; Pfizer, Inc,New York, New York, USA.
  • Liu Q; Pfizer, Inc,New York, New York, USA.
  • Gessner B; Pfizer, Inc,New York, New York, USA.
  • Swerdlow DL; Pfizer, Inc,New York, New York, USA.
  • Kamidani S; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Kao C; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Yildirim I; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Rouphael N; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Rostad CA; Department of Pediatrics (Infectious Diseases), Yale-New Haven Hospital, New Haven, Connecticut, USA.
  • Anderson EJ; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.
Clin Infect Dis ; 78(4): 1065-1072, 2024 Apr 10.
Article em En | MEDLINE | ID: mdl-37946601
ABSTRACT

BACKGROUND:

Data are limited on influenza vaccine effectiveness (VE) in the prevention of influenza-related hospitalizations in older adults and those with underlying high-risk comorbidities.

METHODS:

We conducted a prospective, test-negative, case-control study at 2 US hospitals from October 2018-March 2020 among adults aged ≥50 years hospitalized with acute respiratory illnesses (ARIs) and adults ≥18 years admitted with congestive heart failure (CHF) or chronic obstructive pulmonary disease (COPD) exacerbations. Adults were eligible if they resided in 1 of 8 counties in metropolitan Atlanta, Georgia. Nasopharyngeal and oropharyngeal swabs were tested using BioFire FilmArray (bioMérieux, Inc.) respiratory panel, and standard-of-care molecular results were included when available. Influenza vaccination history was determined from the Georgia vaccine registry and medical records. We used multivariable logistic regression to control for potential confounders and to determine 95% confidence intervals (CIs).

RESULTS:

Among 3090 eligible adults, 1562 (50.6%) were enrolled. Of the 1515 with influenza vaccination history available, 701 (46.2%) had received vaccination during that season. Influenza was identified in 37 (5.3%) vaccinated versus 78 (9.6%) unvaccinated participants. After adjustment for age, race/ethnicity, immunosuppression, month, and season, pooled VE for any influenza-related hospitalization in the eligible study population was 63.1% (95% CI, 43.8-75.8%). Adjusted VE against influenza-related hospitalization for ARI in adults ≥50 years was 55.9% (29.9-72.3%) and adjusted VE against influenza-related CHF/COPD exacerbation in adults ≥18 years was 80.3% (36.3-93.9%).

CONCLUSIONS:

Influenza vaccination was effective in preventing influenza-related hospitalizations in adults aged ≥50 years and those with CHF/COPD exacerbations during the 2018-2020 seasons.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Doença Pulmonar Obstrutiva Crônica / Influenza Humana / Insuficiência Cardíaca Limite: Aged / Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Doença Pulmonar Obstrutiva Crônica / Influenza Humana / Insuficiência Cardíaca Limite: Aged / Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos